The founders of Stemlab, a group of scientists and professionals in the life sciences field, create one the first umbilical cord blood stem cell banks in Europe.
5000 samples stored.
Start of investment in Research & Development of projects related to stem cells.
Opening of the laboratory at Biocant Park. Stemlab is awarded its ISO 9001 certification. First step on the road towards internationalisation, with the start of operations in Italy.
1st transplant in Portugal using a sample stored at Stemlab.
Another step on the road towards internationalisation, with the start of operations in Spain.
An American company acquires a majority share in Stemlab, ensuring major financial support for the daily activities and continuous expansion of the business.
Release of 2 samples for children with cerebral palsy, being part of a pilot study in the US.
Stemlab is awarded its accreditation for cord blood by AABB (American Association of Blood Banks).
Release of 3 more samples.
Launch of the umbilical cord tissue processing service.
Release of another sample.
Registration of the 1st patent for a stem cell based treatment.
Celebration of our 10th anniversary with the certainty of being one of the most trusted cryopreservation brands in Europe.
Over 60,000 families have now chosen us to store their stem cells.
Release of another sample to treat a child with cerebral palsy. This infusion was performed in Madrid, at San Rafael Hospital.
Over 65,000 families have now chosen us to store their stem cells. Extension of our laboratory storage area, becoming 1 of the biggest in Europe with capacity to store up to 300 000 samples.
Stemlab is awarded the brand with the most satisfied consumers in the country of origin for the 3rd consecutive time.
Learn more about the 8 children who have received transplants with stem cells stored at Stemlab.
Frederico was born with severe combined immunodeficiency and it became apparent that he would need a transplant. His parents had chosen to cryopreserve his sibling’s cord blood, and it was these stem cells that helped Frederico in a transplant carried out at the Portuguese Oncology Institute. This rare disease is characterised by immune system deficiencies that make patients vulnerable to serious infections, which are eventually fatal. In Frederico’s case, the solution was a stem cell transplant. The team was led by the Oncology Center’s Immunohemotherapy Department, which decided to use the umbilical cord blood sample from his compatible sibling, stored by Stemlab in 2003. After being contacted by the Oncology Center, Stemlab released the sample to allow the cell conditions to be verified and the sibling compatibility test to be performed. Today, 9 years later, Frederico is completely cured.
While Inês was still growing in the uterus, she suffered intercranial haemorrhage at 36 weeks, which led to cerebral palsy. After consulting with specialist physicians, the decision was taken to treat her with her stem cells. Already after the first infusion, her parents noticed clear improvements of her health and quality of life.
When they found out about the possibility of using the stem cells that they had cryopreserved to treat Afonso’s cerebral palsy, his parents decided to undergo a treatment in the United States. Today, Afonso is more sociable, has more manual dexterity and has better control over his leg movements.
In addition to these three cases, seven other children received stem cell transplants with samples taken at Stemlab: 6 for the treatment of cerebral palsy and one for acute myelogenous leukemia. In all cases, there were significant improvements in the children.
Resuelva todas sus dudas sobre células estaminales, el proceso de criopreservación y Celvitae.